NASDAQ:HYFT

MindWalk Q4 2026 Earnings Results & Report

MindWalk logo
$0.80 -0.10 (-11.11%)
Closing price 11/19/2026 03:59 PM Eastern
Extended Trading
$0.80 +0.00 (+0.38%)
As of 11/19/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MindWalk missed analyst earnings expectations in its Q4 2026 results, released July 22, 2026. The company reported EPS of -$0.06 versus the -$0.05 consensus estimate, while revenue was $3.03 million.

Earnings Announcement Details

Quarter
Q4 2026
Report Date
Time
After Market Closes
Conference Call
5:00 PM ET

MindWalk EPS Results

Actual EPS
-$0.06
Consensus EPS
-$0.05
Beat/Miss
Missed by -$0.01
One Year Ago EPS
N/A

MindWalk Revenue Results

Actual Revenue
$3.03 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

MindWalk Q4 2026 Earnings FAQ

MindWalk (NASDAQ:HYFT) reported earnings of -$0.06 per share for Q4 2026, missing the consensus estimate of -$0.05. The report was announced on Wednesday, July 22, 2026.

MindWalk reported revenue of $3.03 million for Q4 2026.

MindWalk Earnings Headlines

Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel
Why the Next Edge in Antibody Discovery May Be What Labs Remember
See More MindWalk Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like MindWalk? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MindWalk and other key companies, straight to your email.

About MindWalk

MindWalk (NASDAQ:HYFT) is a biotechnology and computational biology company focused on using artificial intelligence and data analysis to support biological research and drug discovery.

The company’s proprietary Hyft technology is designed to identify patterns in biological data, including genomic and other biomolecular information. MindWalk positions its platform as a tool for researchers and life-sciences organizations seeking insights that can inform therapeutic research and development.

View MindWalk Profile